Mandate

Vinge represented the sellers in the divestment of Fred Holmberg & Co AB

December 31, 2014

Vinge represented the sellers in the divestment of Fred Holmberg & Co AB to Brenntag Nordic AB. Fred Holmberg & Co AB is active within the field of distribution of chemicals, biofuels and products for NOx reduction and has an expected turnover of more than SEK 700 million for 2014. Brenntag is the world leader in chemicals distribution and the acquisition strengthens Brenntag’s presence on the Nordic market.

Vinge’s team consisted of partner Jesper Ottergren together with associate Fredrik Christiansson. In addition, specialist Mathias Lindqvist has assisted with environmental law expertise and partner Pär Remnelid, together with associate Lisa Bourghardt, have assisted with competition law expertise.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026